Reena Sharma

Suggest Changes
Learn More
Toxic optic neuropathy (TON) is a disease entity which is not only underdiagnosed, but also often diagnosed at a stage when recovery of vision is not possible. This article gives an overview of(More)
AIM In this study, efficacy, tolerability and safety of biosimilar adalimumab (Exemptia; Zydus Cadila) was compared with reference adalimumab (Humira; AbbVie) in patients with moderate to severe(More)
BACKGROUND Numerous therapeutic options have been tried in the management of melasma. AIMS AND OBJECTIVES This prospective randomized study was planned to assess the efficacy of low potency triple(More)